GAD1 and Anxiety: A significant main effect was observed on GAD-7 (F1,54=9.24; P=.004) suggesting that completers experienced a significant reduction in symptoms of anxiety between baseline and T2, regardless of the group to which they were assigned with a within-subjects effect size of d=0.37.